1353 related articles for article (PubMed ID: 16415884)
1. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes.
Grant SF; Thorleifsson G; Reynisdottir I; Benediktsson R; Manolescu A; Sainz J; Helgason A; Stefansson H; Emilsson V; Helgadottir A; Styrkarsdottir U; Magnusson KP; Walters GB; Palsdottir E; Jonsdottir T; Gudmundsdottir T; Gylfason A; Saemundsdottir J; Wilensky RL; Reilly MP; Rader DJ; Bagger Y; Christiansen C; Gudnason V; Sigurdsson G; Thorsteinsdottir U; Gulcher JR; Kong A; Stefansson K
Nat Genet; 2006 Mar; 38(3):320-3. PubMed ID: 16415884
[TBL] [Abstract][Full Text] [Related]
2. Haplotypes of transcription factor 7-like 2 (TCF7L2) gene and its upstream region are associated with type 2 diabetes and age of onset in Mexican Americans.
Lehman DM; Hunt KJ; Leach RJ; Hamlington J; Arya R; Abboud HE; Duggirala R; Blangero J; Göring HH; Stern MP
Diabetes; 2007 Feb; 56(2):389-93. PubMed ID: 17259383
[TBL] [Abstract][Full Text] [Related]
3. Association study of the genetic polymorphisms of the transcription factor 7-like 2 (TCF7L2) gene and type 2 diabetes in the Chinese population.
Chang YC; Chang TJ; Jiang YD; Kuo SS; Lee KC; Chiu KC; Chuang LM
Diabetes; 2007 Oct; 56(10):2631-7. PubMed ID: 17579206
[TBL] [Abstract][Full Text] [Related]
4. Loci of TCF7L2, HHEX and IDE on chromosome 10q and the susceptibility of their genetic polymorphisms to type 2 diabetes.
Nordman S; Ostenson CG; Efendic S; Gu HF
Exp Clin Endocrinol Diabetes; 2009 Apr; 117(4):186-90. PubMed ID: 19053027
[TBL] [Abstract][Full Text] [Related]
5. The DG10S478 variant in the TCF7L2 gene is not associated with microvascular complications in type 2 diabetes.
Buchbinder S; Rudofsky G; Humpert PM; Schilling T; Zorn M; Bierhaus A; Nawroth PP
Exp Clin Endocrinol Diabetes; 2008 Apr; 116(4):211-4. PubMed ID: 18072015
[TBL] [Abstract][Full Text] [Related]
6. Transcription factor TCF7L2 genetic study in the French population: expression in human beta-cells and adipose tissue and strong association with type 2 diabetes.
Cauchi S; Meyre D; Dina C; Choquet H; Samson C; Gallina S; Balkau B; Charpentier G; Pattou F; Stetsyuk V; Scharfmann R; Staels B; Frühbeck G; Froguel P
Diabetes; 2006 Oct; 55(10):2903-8. PubMed ID: 17003360
[TBL] [Abstract][Full Text] [Related]
7. Comparison of genetic risk in three candidate genes (TCF7L2, PPARG, KCNJ11) with traditional risk factors for type 2 diabetes in a population-based study--the HUNT study.
Thorsby PM; Midthjell K; Gjerlaugsen N; Holmen J; Hanssen KF; Birkeland KI; Berg JP
Scand J Clin Lab Invest; 2009; 69(2):282-7. PubMed ID: 18972257
[TBL] [Abstract][Full Text] [Related]
8. Whole-grain consumption and transcription factor-7-like 2 ( TCF7L2) rs7903146: gene-diet interaction in modulating type 2 diabetes risk.
Fisher E; Boeing H; Fritsche A; Doering F; Joost HG; Schulze MB
Br J Nutr; 2009 Feb; 101(4):478-81. PubMed ID: 19149908
[TBL] [Abstract][Full Text] [Related]
9. TCF7L2 polymorphisms are associated with type 2 diabetes in northern Sweden.
Mayans S; Lackovic K; Lindgren P; Ruikka K; Agren A; Eliasson M; Holmberg D
Eur J Hum Genet; 2007 Mar; 15(3):342-6. PubMed ID: 17245407
[TBL] [Abstract][Full Text] [Related]
10. Transcription factor 7-like 2 (TCFL2) - a novel factor involved in pathogenesis of type 2 diabetes. Comment on: Grant et al., Nature Genetics 2006, Published online 15 January 2006.
Kiessling A; Ehrhart-Bornstein M
Horm Metab Res; 2006 Feb; 38(2):137-8. PubMed ID: 16523417
[No Abstract] [Full Text] [Related]
11. Association of TCF7L2 polymorphisms with type 2 diabetes in Mexico City.
Parra EJ; Cameron E; Simmonds L; Valladares A; McKeigue P; Shriver M; Wacher N; Kumate J; Kittles R; Cruz M
Clin Genet; 2007 Apr; 71(4):359-66. PubMed ID: 17470138
[TBL] [Abstract][Full Text] [Related]
12. Testing the gene or testing a variant? The case of TCF7L2.
Goodarzi MO; Rotter JI
Diabetes; 2007 Oct; 56(10):2417-9. PubMed ID: 17901222
[No Abstract] [Full Text] [Related]
13. Common single nucleotide polymorphisms in TCF7L2 are reproducibly associated with type 2 diabetes and reduce the insulin response to glucose in nondiabetic individuals.
Saxena R; Gianniny L; Burtt NP; Lyssenko V; Giuducci C; Sjögren M; Florez JC; Almgren P; Isomaa B; Orho-Melander M; Lindblad U; Daly MJ; Tuomi T; Hirschhorn JN; Ardlie KG; Groop LC; Altshuler D
Diabetes; 2006 Oct; 55(10):2890-5. PubMed ID: 17003358
[TBL] [Abstract][Full Text] [Related]
14. The new type 2 diabetes gene TCF7L2.
Florez JC
Curr Opin Clin Nutr Metab Care; 2007 Jul; 10(4):391-6. PubMed ID: 17563454
[TBL] [Abstract][Full Text] [Related]
15. Transcription factor 7-like 2 (TCF7L2) variant is associated with familial breast cancer risk: a case-control study.
Burwinkel B; Shanmugam KS; Hemminki K; Meindl A; Schmutzler RK; Sutter C; Wappenschmidt B; Kiechle M; Bartram CR; Frank B
BMC Cancer; 2006 Nov; 6():268. PubMed ID: 17109766
[TBL] [Abstract][Full Text] [Related]
16. Variants of the transcription factor 7-like 2 gene (TCF7L2) are strongly associated with type 2 diabetes but not with the metabolic syndrome in the MONICA/KORA surveys.
Marzi C; Huth C; Kolz M; Grallert H; Meisinger C; Wichmann HE; Rathmann W; Herder C; Illig T
Horm Metab Res; 2007 Jan; 39(1):46-52. PubMed ID: 17226113
[TBL] [Abstract][Full Text] [Related]
17. Additive effects of obesity and TCF7L2 variants on risk for type 2 diabetes among cardiac patients.
Duan QL; Dubé MP; Frasure-Smith N; Barhdadi A; Lesperance F; Théroux P; St-Onge J; Rouleau GA; McCaffery JM
Diabetes Care; 2007 Jun; 30(6):1621-3. PubMed ID: 17351281
[No Abstract] [Full Text] [Related]
18. TCF7L2 variation predicts hyperglycemia incidence in a French general population: the data from an epidemiological study on the Insulin Resistance Syndrome (DESIR) study.
Cauchi S; Meyre D; Choquet H; Dina C; Born C; Marre M; Balkau B; Froguel P;
Diabetes; 2006 Nov; 55(11):3189-92. PubMed ID: 17065361
[TBL] [Abstract][Full Text] [Related]
19. Role of Wnt signaling in the development of type 2 diabetes.
Bordonaro M
Vitam Horm; 2009; 80():563-81. PubMed ID: 19251050
[TBL] [Abstract][Full Text] [Related]
20. TCF7L2 gene expression in human visceral and subcutaneous adipose tissue is differentially regulated but not associated with type 2 diabetes mellitus.
Kovacs P; Berndt J; Ruschke K; Klöting N; Schön MR; Körner A; Stumvoll M; Blüher M
Metabolism; 2008 Sep; 57(9):1227-31. PubMed ID: 18702948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
